Coherus Oncology Inc at TD Cowen Healthcare Conference Transcript
Great. Welcome everybody to the coherent session. Thanks so much for your time. My name is Mike Nedelcovych. I'm part of the TDcom research team. I'm very pleased to be joined by Denny, who's the CEO of Coherence Psychology and Teresa, the head of research.
Questions & Answers
I, I'll start with a big picture picture question. And it's one that's very important to the company. You've affected a very impressive strategic transition to an innovative oncology biotech, and you have an approved drug in Loc Torzi, which is a relatively unique position to be in. Can you describe the rationale behind that shift and what it's taken you to get here?
No, thanks for the question, Michael, and thank you to the bank and our long standing relationship for your, invitation to say. So, it's been a lot of fun. I think we managed to move, pretty
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
